Soo Teik Lim

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

Michael Haude, Hüseyin İnce, Alexandre Abizaid et al. · The Lancet · 2015 · 353 citations

Medicine, Cardiology, Clinical Sciences +17

Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with<i>de novo</i>coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Michael Haude, Hüseyin İnce, Alexandre Abizaid et al. · European Heart Journal · 2016 · 185 citations · Full text

Medicine, Cardiology, Pharmacology +17

Recurrence after Successful Percutaneous Endoscopic Lumbar Discectomy

Jae Hyun Kim, Sang‐Ho Lee, Yong Ahn et al. · min - Minimally Invasive Neurosurgery · 2007 · 145 citations

Medicine, Orthopedic Surgery, Surgery +14

Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Hyun‐Jae Kang, Robert M. Clare, Claes Held et al. · American Heart Journal · 2015 · 111 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)

Robert F. Storey, Richard C. Becker, Robert A. Harrington et al. · The American Journal of Cardiology · 2011 · 68 citations

Medicine, Cardiology, Pharmacotherapy +16